Emkay Global Financial' research report on Sagar Cement
Sagar Cement’s Q2FY23 EBITDA sharply declined by 91% YoY and QoQ to Rs57mn vs. our estimate of Rs156mn (Consensus: Rs234mn) owing to higher-than-expected increase in cost/ton. Accordingly, EBITDA/ton declined to just Rs55 (Emkay est.: Rs150). Volume growth remains superior at 21% YoY to 1.03mt, in line with our estimates. The company has recently increased its capacity by 43% to 8.3mt. Sagar is expected to register an industry-leading volume CAGR of 19% over FY22-25E, aided by a low base effect and capacity expansion. The company is also expanding its footprint to the East and Central regions, which would lead to reduced earnings volatility. In May-22, the company issued 13.2mn equity shares (10% stake) to Premji Invest at Rs265/share, totaling Rs3.5bn, to fund growth capex. Factoring in Q2FY23 miss and higher opex/ton, we reduce our FY23 EBITDA estimates by 29% and 4-6% for FY24E and FY25E, respectively.
Outlook
We maintain our Buy rating on the stock with a revised Sep-23 TP to Rs220 (earlier Rs225) post the quarterly rollover. Our DCF-based TP implies a one-year forward EV/EBITDA of 8x.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.